References analysis of the Wikipedia article "Angiogenesis inhibitor" in the English version

doi.org (Global: 2^nd place; English: 2^nd place)

Hayden EC (April 2009). "Cutting off cancer's supply lines". Nature. 458 (7239): 686–687. doi:10.1038/458686b. PMID 19360048.

Ng EW, Adamis AP (June 2005). "Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration". Canadian Journal of Ophthalmology. 40 (3): 352–368. doi:10.1016/S0008-4182(05)80078-X. PMID 15947805.

Folkman J (2004). "Endogenous angiogenesis inhibitors". APMIS. 112 (7–8): 496–507. doi:10.1111/j.1600-0463.2004.apm11207-0809.x. PMID 15563312. S2CID 10605205.

Milosevic V, Edelmann RJ, Fosse JH, Östman A, Akslen LA (2022), Akslen LA, Watnick RS (eds.), "Molecular Phenotypes of Endothelial Cells in Malignant Tumors", Biomarkers of the Tumor Microenvironment, Cham: Springer International Publishing, pp. 31–52, doi:10.1007/978-3-030-98950-7_3, ISBN 978-3-030-98950-7, retrieved 2022-07-13

Cao Y (April 2001). "Endogenous angiogenesis inhibitors and their therapeutic implications". The International Journal of Biochemistry & Cell Biology. 33 (4): 357–369. doi:10.1016/s1357-2725(01)00023-1. PMID 11312106.

Kazazi-Hyseni F, Beijnen JH, Schellens JH (2010-08-01). "Bevacizumab". The Oncologist. 15 (8): 819–825. doi:10.1634/theoncologist.2009-0317. ISSN 1083-7159. PMC 3228024. PMID 20688807.

Ferrara N, Hillan KJ, Novotny W (2005). "Bevacizumab (Avastin), a humanized anti-VEGF monoclonal antibody for cancer therapy". Biochemical and Biophysical Research Communications. 333 (2): 328–335. doi:10.1016/j.bbrc.2005.05.132. PMID 15961063.

Rini BI (February 2007). "Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current status and future directions". Clinical Cancer Research. 13 (4): 1098–1106. doi:10.1158/1078-0432.CCR-06-1989. PMID 17317817.

Nyberg P, Xie L, Kalluri R (May 2005). "Endogenous inhibitors of angiogenesis". Cancer Research. 65 (10): 3967–3979. doi:10.1158/0008-5472.CAN-04-2427. PMID 15899784.

Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, Maeshima Y, Mier JW, Sukhatme VP, Kalluri R (January 2000). "Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth". The Journal of Biological Chemistry. 275 (2): 1209–1215. doi:10.1074/jbc.275.2.1209. PMID 10625665.

Lee SJ, Nathans D (March 1988). "Proliferin secreted by cultured cells binds to mannose 6-phosphate receptors". The Journal of Biological Chemistry. 263 (7): 3521–3527. doi:10.1016/S0021-9258(18)69101-X. PMID 2963825.

Farina HG, Pomies M, Alonso DF, Gomez DE (October 2006). "Antitumor and antiangiogenic activity of soy isoflavone genistein in mouse models of melanoma and breast cancer". Oncology Reports. 16 (4): 885–891. doi:10.3892/or.16.4.885. PMID 16969510.

Kimura Y, Kido T, Takaku T, Sumiyoshi M, Baba K (September 2004). "Isolation of an anti-angiogenic substance from Agaricus blazei Murill: its antitumor and antimetastatic actions". Cancer Science. 95 (9): 758–64. doi:10.1111/j.1349-7006.2004.tb03258.x. PMC 11159378. PMID 15471563. S2CID 7243576.

Takaku T, Kimura Y, Okuda H (May 2001). "Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action". The Journal of Nutrition. 131 (5): 1409–1413. doi:10.1093/jn/131.5.1409. PMID 11340091.

Liu Z, Schwimer J, Liu D, Greenway FL, Anthony CT, Woltering EA (2005). "Black Raspberry Extract and Fractions Contain Angiogenesis Inhibitors". Journal of Agricultural and Food Chemistry. 53 (10): 3909–3915. doi:10.1021/jf048585u. PMID 15884816.

Stanley G, Harvey K, Slivova V, Jiang J, Sliva D (April 2005). "Ganoderma lucidum suppresses angiogenesis through the inhibition of secretion of VEGF and TGF-beta1 from prostate cancer cells". Biochemical and Biophysical Research Communications. 330 (1): 46–52. doi:10.1016/j.bbrc.2005.02.116. PMID 15781230.

Oba K, Teramukai S, Kobayashi M, Matsui T, Kodera Y, Sakamoto J (June 2007). "Efficacy of adjuvant immunochemotherapy with polysaccharide K for patients with curative resections of gastric cancer". Cancer Immunol Immunother. 56 (6): 905–911. doi:10.1007/s00262-006-0248-1. PMC 11030720. PMID 17106715. S2CID 161680.

Lee JS, Park BC, Ko YJ, Choi MK, Choi HG, Yong CS, Lee JS, Kim JA (December 2008). "Grifola frondosa (maitake mushroom) water extract inhibits vascular endothelial growth factor-induced angiogenesis through inhibition of reactive oxygen species and extracellular signal-regulated kinase phosphorylation". Journal of Medicinal Food. 11 (4): 643–51. doi:10.1089/jmf.2007.0629. PMID 19053855.

Sliva D, Jedinak A, Kawasaki J, Harvey K, Slivova V (April 2008). "Phellinus linteus suppresses growth, angiogenesis and invasive behaviour of breast cancer cells through the inhibition of AKT signalling". British Journal of Cancer. 98 (8): 1348–1356. doi:10.1038/sj.bjc.6604319. PMC 2361714. PMID 18362935.

Lee YS, Kang YH, Jung JY, Lee S, Ohuchi K, Shin KH, Kang IJ, Park JH, Shin HK, Lim SS, et al. (October 2008). "Protein glycation inhibitors from the fruiting body of Phellinus linteus". Biological & Pharmaceutical Bulletin. 31 (10): 1968–1972. doi:10.1248/bpb.31.1968. PMID 18827365.

Rodriguez SK, Guo W, Liu L, Band MA, Paulson EK, Meydani M (April 2006). "Green tea catechin, epigallocatechin-3-gallate, inhibits vascular endothelial growth factor angiogenic signaling by disrupting the formation of a receptor complex". International Journal of Cancer. 118 (7): 1635–1644. doi:10.1002/ijc.21545. PMID 16217757. S2CID 6846032.

Jeong SJ, Koh W, Lee EO, Lee HJ, Lee HJ, Bae H, Lü J, Kim SH (January 2011). "Antiangiogenic phytochemicals and medicinal herbs". Phytotherapy Research. 25 (1): 1–10. doi:10.1002/ptr.3224. PMID 20564543. S2CID 968172.

Izuta H, Chikaraishi Y, Shimazawa M, Mishima S, Hara H (December 2009). "10-Hydroxy-2-decenoic acid, a major fatty acid from royal jelly, inhibits VEGF-induced angiogenesis in human umbilical vein endothelial cells". Evidence-Based Complementary and Alternative Medicine. 6 (4): 489–494. doi:10.1093/ecam/nem152. PMC 2781774. PMID 18955252.

Bruemmer D (February 2012). "Targeting angiogenesis as treatment for obesity". Arteriosclerosis, Thrombosis, and Vascular Biology. 32 (2): 161–162. doi:10.1161/ATVBAHA.111.241992. PMID 22258895.

Heier JS (May 2013). "Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments". Ophthalmology. 120 (5 Suppl): S23–25. doi:10.1016/j.ophtha.2013.01.059. PMID 23642783.

Chong CR, Xu J, Lu J, Bhat S, Sullivan DJ, Liu JO (April 2007). "Inhibition of angiogenesis by the antifungal drug itraconazole". ACS Chemical Biology. 2 (4): 263–70. doi:10.1021/cb600362d. PMID 17432820.

Aftab BT, Dobromilskaya I, Liu JO, Rudin CM (November 2011). "Itraconazole inhibits angiogenesis and tumor growth in non-small cell lung cancer". Cancer Research. 71 (21): 6764–6772. doi:10.1158/0008-5472.CAN-11-0691. PMC 3206167. PMID 21896639.

Xu J, Dang Y, Ren YR, Liu JO (March 2010). "Cholesterol trafficking is required for mTOR activation in endothelial cells". Proceedings of the National Academy of Sciences of the United States of America. 107 (10): 4764–9. Bibcode:2010PNAS..107.4764X. doi:10.1073/pnas.0910872107. PMC 2842052. PMID 20176935.

Goya Grocin A, Kallemeijn WW, Tate EW (October 2021). "Targeting methionine aminopeptidase 2 in cancer, obesity, and autoimmunity". Trends in Pharmacological Sciences. 42 (10): 870–882. doi:10.1016/j.tips.2021.07.004. hdl:10044/1/102175. PMID 34446297.

Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, Kim RY (October 2006). "Ranibizumab for neovascular age-related macular degeneration". The New England Journal of Medicine. 355 (14): 1419–1431. doi:10.1056/NEJMoa054481. PMID 17021318.

Kim JH, Scialli AR (July 2011). "Thalidomide: the tragedy of birth defects and the effective treatment of disease". Toxicological Sciences. 122 (1): 1–6. doi:10.1093/toxsci/kfr088. PMID 21507989.

Blázquez C, González-Feria L, Alvarez L, Haro A, Casanova ML, Guzmán M (August 2004). "Cannabinoids inhibit the vascular endothelial growth factor pathway in gliomas". Cancer Research. 64 (16): 5617–5623. doi:10.1158/0008-5472.CAN-03-3927. PMID 15313899. S2CID 1357974.

Elice F, Rodeghiero F (April 2012). "Side effects of anti-angiogenic drugs". Thrombosis Research. 129: S50–53. doi:10.1016/S0049-3848(12)70016-6. PMID 22682133.

Maitland ML, Kasza KE, Karrison T, Moshier K, Sit L, Black HR, Undevia SD, Stadler WM, Elliott WJ, Ratain MJ (October 2009). "Ambulatory monitoring detects sorafenib-induced blood pressure elevations on the first day of treatment". Clinical Cancer Research. 15 (19): 6250–6257. doi:10.1158/1078-0432.CCR-09-0058. PMC 2756980. PMID 19773379.

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

Hayden EC (April 2009). "Cutting off cancer's supply lines". Nature. 458 (7239): 686–687. doi:10.1038/458686b. PMID 19360048.

Fukumura, D., et al., Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges. Nat Rev Clinical Oncology, 2018. 15(5): pp. 325–340. doi: 10.1038/nrclinonc.2018.29.

Huinen, Z., et al., Anti-angiogenic agents – overcoming tumor endothelial cell anergy and improving immunotherapy outcomes. Nat. Rev. Clinical Oncology, 2021. 18(8): pp. 527–540. doi: 10.1038/s41571-021-00496-y.

Dudley, A.C. & Griffioen, A.W., Pathological angiogenesis: mechanisms and therapeutic strategies. Angiogenesis, 2023. doi: 10.1007/s10456-023-09876-7

Folkman J (2004). "Endogenous angiogenesis inhibitors". APMIS. 112 (7–8): 496–507. doi:10.1111/j.1600-0463.2004.apm11207-0809.x. PMID 15563312. S2CID 10605205.

Kazazi-Hyseni F, Beijnen JH, Schellens JH (2010-08-01). "Bevacizumab". The Oncologist. 15 (8): 819–825. doi:10.1634/theoncologist.2009-0317. ISSN 1083-7159. PMC 3228024. PMID 20688807.

Nyberg P, Xie L, Kalluri R (May 2005). "Endogenous inhibitors of angiogenesis". Cancer Research. 65 (10): 3967–3979. doi:10.1158/0008-5472.CAN-04-2427. PMID 15899784.

Fisher M, Yang LX (May 2002). "Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy". Anticancer Research. 22 (3): 1737–1754. PMID 12168863.

Kobayashi H, Matsunaga K, Oguchi Y (1995). "Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview". Cancer Epidemiology, Biomarkers & Prevention. 4 (3): 275–281. PMID 7606203.

Bruemmer D (February 2012). "Targeting angiogenesis as treatment for obesity". Arteriosclerosis, Thrombosis, and Vascular Biology. 32 (2): 161–162. doi:10.1161/ATVBAHA.111.241992. PMID 22258895.

Ruch JM, Hussain MH (15 May 2011). "Evolving Therapeutic Paradigms for Advanced Prostate Cancer". Oncology. 25 (6): 496–504, 508. PMID 21717904. Retrieved 9 May 2022.

Elice F, Rodeghiero F (April 2012). "Side effects of anti-angiogenic drugs". Thrombosis Research. 129: S50–53. doi:10.1016/S0049-3848(12)70016-6. PMID 22682133.

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

Folkman J (2004). "Endogenous angiogenesis inhibitors". APMIS. 112 (7–8): 496–507. doi:10.1111/j.1600-0463.2004.apm11207-0809.x. PMID 15563312. S2CID 10605205.

web.archive.org (Global: 1^st place; English: 1^st place)

Cancer.com [homepage on the Internet]. National Cancer Institute at the National Institutes of Health; 2011 [cited 18 March 2014]. Available from: "Angiogenesis Inhibitors". Archived from the original on 2015-02-08. Retrieved 2022-05-09.

Smith, Roderick. Antiangiogenic Substances in Blackberries, Licorice May Aid Cancer Prevention.. Archived 2010-02-14 at the Wayback Machine. The Angiogenesis Foundation. 6 May 2009.^{[unreliable medical source?]}

FDA News Release on Avastin, archived from the original on November 20, 2011, retrieved 2014-04-15

Angiogenesis inhibitor (English Wikipedia)

angio.org (Global: low place; English: low place)

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

cancernetwork.com (Global: low place; English: low place)

clinicaltrialsarena.com (Global: low place; English: low place)

doi.org (Global: 2^nd place; English: 2^nd place)

elsevier.com (Global: 610^th place; English: 704^th place)

linkinghub.elsevier.com

fda.gov (Global: 447^th place; English: 338^th place)

handle.net (Global: 102^nd place; English: 76^th place)

hdl.handle.net

harvard.edu (Global: 18^th place; English: 17^th place)

ui.adsabs.harvard.edu

hemonc.org (Global: low place; English: low place)

nih.gov (Global: 4^th place; English: 4^th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11^th place; English: 8^th place)

api.semanticscholar.org

spandidos-publications.com (Global: low place; English: low place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)

search.worldcat.org

Angiogenesis inhibitor (English Wikipedia)

angio.org (Global: low place; English: low place)

cancer.gov (Global: 1,684th place; English: 1,350th place)

cancernetwork.com (Global: low place; English: low place)

clinicaltrialsarena.com (Global: low place; English: low place)

doi.org (Global: 2nd place; English: 2nd place)

elsevier.com (Global: 610th place; English: 704th place)

linkinghub.elsevier.com

fda.gov (Global: 447th place; English: 338th place)

handle.net (Global: 102nd place; English: 76th place)

hdl.handle.net

harvard.edu (Global: 18th place; English: 17th place)

ui.adsabs.harvard.edu

hemonc.org (Global: low place; English: low place)

nih.gov (Global: 4th place; English: 4th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

semanticscholar.org (Global: 11th place; English: 8th place)

api.semanticscholar.org

spandidos-publications.com (Global: low place; English: low place)

web.archive.org (Global: 1st place; English: 1st place)

worldcat.org (Global: 5th place; English: 5th place)

search.worldcat.org

cancer.gov (Global: 1,684^th place; English: 1,350^th place)

doi.org (Global: 2^nd place; English: 2^nd place)

elsevier.com (Global: 610^th place; English: 704^th place)

fda.gov (Global: 447^th place; English: 338^th place)

handle.net (Global: 102^nd place; English: 76^th place)

harvard.edu (Global: 18^th place; English: 17^th place)

nih.gov (Global: 4^th place; English: 4^th place)

semanticscholar.org (Global: 11^th place; English: 8^th place)

web.archive.org (Global: 1^st place; English: 1^st place)

worldcat.org (Global: 5^th place; English: 5^th place)